Investing in Vaccines for Developing Countries: How Public-Private Partnerships Can Confront Neglected Diseases

This commentary discusses the barrier of vaccine price on sustainable immunization programs in developing countries and offers examples of new mechanisms driven by public-private partnerships to overcome issues of affordability.

Author(s): Yaïch M

Published: 2009

  • Visit website (English)

    (Located at www.landesbioscience.com)

    Yaich M. Investing in vaccines for developing countries: How public-private partnerships can confront neglected diseases. Human Vaccines. 2009;5(6).

Resource types: Peer-reviewed journal

Diseases: Not disease/vaccine specific

Topics: Immunization financing

Regions: Global